Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Response to hypertensive effects of Bay-k-8644 is enhanced in pregnancy

Nov. 24, 1998

Diovan reduces left ventricular hypertrophy in hypertensive patients

Nov. 23, 1998

Adenosine + thrombolytics further reduces infarct size in acute MI; phase III trials in preparation

Nov. 23, 1998

New MMP inhibitor from Roche Bioscience limits arterial enlargement in rat model of AVF

Nov. 23, 1998

Celgene describes SelCID compounds for treatment of CHF

Nov. 20, 1998

Nortran enters collaborative agreement with Astra

Nov. 20, 1998

Ozagrel hydrochloride effectively prevents development of preeclampsia in pregnant women

Nov. 19, 1998

Safe and effective treatment of acute CHF with nesiritide

Nov. 19, 1998

Endothelin antagonists a focus of R&D at Merck KGaA

Nov. 19, 1998

New compound described for the treatment of pregnancy-induced hypertension

Nov. 19, 1998

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...